Serum thrombin time in clinical medicine

Details Serum thrombin time in clinical medicine Serum thrombin time in clinical medicine

1984-05-14

1986-01-28

Marantz, Sidney

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving blood clotting factor

73 55, 128637, 436 69, G01N 3348, G01N 3368, G01N 3386, G01N 3396

Patent

active

045671370

ABSTRACT:
A solution of purified, standardized fibrinogen is added to a sample of coagulant-free serum from subject, and the serum thrombin time is determined. The measurement may be related to diagnosing an abnormal body condition, such as schizophrenia, or selecting the optimum chemotherapeutic agent in treatment.

REFERENCES:
patent: 3342063 (1967-09-01), Smythe
patent: 3861197 (1975-01-01), Adler
patent: 3911728 (1975-10-01), Fixot
patent: 3960669 (1976-06-01), Innerfield
patent: 3990947 (1976-11-01), Butler
patent: 3999538 (1976-12-01), Philpot
patent: 4081242 (1978-03-01), Girolami
patent: 4083363 (1978-04-01), Philpot
patent: 4165632 (1979-08-01), Weber
patent: 4300551 (1981-11-01), Kinney
patent: 4461830 (1984-07-01), Philpot
Chemical Abstracts, 91:72753z (1979).
Chemical Abstracts, 95:59360y (1981).

Affiliated with

Also associated with

Rating

Serum thrombin time in clinical medicine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Serum thrombin time in clinical medicine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serum thrombin time in clinical medicine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1306211